Abstract
The human adrenal cortex secretes three classes of steroid hormone: glucocorticoid, mineralcorticoid and the so-called adrenal androgens, dehydroepiandrosterone (DHEA) and DHEA-sulfate. The term adrenal androgen is not strictly accurate since DHEA per se is not androgenic and only through metabolism to steroids such as testosterone does it exert such action. DHEA-sulfate is also a principal source of estrogen, through placental metabolism, in the pregnant female1,2. However, in the normal male and female the proportion of sex steroids derived from adrenal DHEA is very small compared to the gonadal contribution, and the significance of the adrenal secretion of DHEA and DHEA-sulfate remains unclear3.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. E. Baulieu and F. Dray, Conversion of [3H]dehydroisoandrosterone (3 ß-hydroxy-Δ5-androsten-17-one) sulfate to [3H]estrogens in normal pregnant women, J. Clin. Endocrinol. Metab. 23:1298 (1963).
P. K. Siiteri and P. C. MacDonald, The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy, Steroids 2:713 (1963).
S. Lieberman, Pictorial endocrinology and empirical hormonology, The Sir Henry Dale Lecture for 1986, J. Endocr. 111:519 (1986).
N. Orentriech, J. L. Brind, R. L. Rizer and J. H. Vogelman, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J. Clin. Endocrinol. Metab. 59:551 (1984).
C. Gherondache, L. Romanoff and G. Pincus, Steroid hormones in aging men, in: “Endocrines and Aging”, L. Gitman, ed., Charles Thomas, Springfield, IL (1967).
P. Weidman, S. deMyttenaere-Bursztein, M. Maxwell, and J. deLima, Effect of aging on plasma renin and aldosterone in normal man, Kidney Int. 8:325 (1975).
L. Parker, T. Gral, V. Perrigo and R. Shorosky, Decreased adrenal androgen sensitivity to ACTH during aging, Metabolism 30:601 (1981).
R. D. Bulbrook, J. L. Hayward, C. C. Spicer and B. S. Thomas, Abnormal excretion of urinary steroids by women with early breast cancer Lancet ii:1238 (1962).
R. D. Bulbrook, J. L. Hayward and C. C. Spicer, Relation between urinary androgen and corticoid excretion and subsequent breast cancer, Lancet ii:395 (1971).
A. G. Schwartz, Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone, Cancer Res. 39:1129 (1979).
A. G. Schwartz and R. H. Tannen, Inhibition of 7,12-dimethylbenz(a)anthracene-and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone, Carcinogenesis 2:1335 (1981).
J. W. Nyce, P. N. Magee, G. C. Hard and A. G. Schwartz, Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone, Carcinogenesis 5:57 (1984).
M. A. Moore, W. Thamavit, A. Tsuda, K. Sato, A. Ichihara and N. Ito, Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats, Carcinogenesis 7:311 (1986).
R. Garcea, L. Daino, R. Pascale, S. Frassetto, P. Cozzolino, M. E. Ruggiu and F. Feo, Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis, Toxicol. Path. 15:164 (1987).
L. L. Pashko, R. J. Rovito, J. R. Williams, E. L. Sobel and A. G. Schwartz, Dehydroepiandrosterone (DHEA) and 3 ß-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz(a)anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice, Carcinogenesis 5:463 (1984).
L. L. Pashko, G. C. Hard, R. J. Rovito, J. R. Williams, E. L. Sobel and A. G. Schwartz, Inhibition of 7,12-dimethylbenz(a)anthraceneinduced skin papillomas and carcinomas by dehydroepiandrosterone and 3 ß-methylandrost-5-en-17-one in mice, Cancer Res. 45:164 (1985).
P. A. Marks and J. Banks, Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids, Proc. Natl. Acad. Sci. USA 46:447 (1960).
G. W. Oertel and P. Benes, The effects of steroids on glucose-6-phosphate dehydrogenase, J. Steroid Biochem. 3:493 (1972).
A. G. Schwartz and A. Perantoni, Protective effect of dehydroepiandrosterone against aflatoxin B1, and 7,12-dimethylbenz(a)anthraceneinduced cytotoxicity and transformation in cultured cells, Cancer Res. 35:2482 (1975).
J. A. Miller, Carcinogenesis by chemicals: an overview, Cancer Res. 30:559 (1970).
F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto, R. Garcea and L. Gaspa, Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts, Cancer Res. 44:3419 (1984).
F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto, S. Zanetti and R. Garcea, 1984, Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in benzo(a)pyrene activation, Toxicol. Path. 11:261 (1984).
L. L. Pashko and A. G. Schwartz, Effect of food restriction, dehydroepiandrosterone, or obesity on the binding of [3H]-7,12-dimethylbenz(a)anthracene to mouse skin DNA, J. Gerontol. 38:8 (1983).
T. S. Argyris, Nature of epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice, Cancer Res. 43:1768 (1983).
V. Kinzel, H. Lochrke, L. Goertler, G. Fürstenberger and F. Marks, Suppression of the first stage of phorbol 12-tetradecanoate-13-acetateeffected tumor promotion in mouse skin by non-toxic inhibition of DNA synthesis, Proc. Natl. Acad. Sci. USA 81:5858 (1984).
L. L. Pashko, A. G. Schwartz, M. Abou-Gharbia and D. Swern, Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids, Carcinogenesis 2:717 (1981).
R. Raineri and H. R. Levy, On the specificity of steroid interaction with mammary gland glucose-6-phosphate dehydrogenase, Biochemistry 9:2233 (1970).
C. W. Castor and B. L. Baker, The local action of adrenocortical steroids on epidermis and connective tissue of the skin, J. Endocrinol. 47:234 (1950).
H. Green and O. Kehinde, An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion, Cell 5:19 (1975).
G. B. Gordon, J. A. Newitt, L. M. Shantz, D. E. Weng and P. Talalay, Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids, Cancer Res. 46:3389 (1986).
C. R. Dworkin, S. D. Gorman, L. L. Pashko, V. J. Cristofallo and A. G. Schwartz, Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides, Life Sci. 38:1451 (1986).
G. B. Gordon, L. M. Shantz and P. Talalay, Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone, Adv. Enzyme Regulation 26:355 (1987).
F. Feo, R. Garcea, L. Daino, S. Frassetto, P. Cozzolino, M. E. Ruggiu, M. G. Vannini, R. Pascale, L. Lenzerini, M. M. Simile and M. Puddu, Inhibition of hepatocarcinogenesis promotion by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides, Fourth Sardinian International Meeting: Models and Mechanisms in Chemical Carcinogenesis, abstract, (1987).
B. M. Babior, The enzymatic basis for 0• 2 production by human neutrophils, Can. J. Physiol. Pharmacol. 60:1353 (1982).
I. Emerit and P. Cerutti, Clastogenic action of tumor promoter phorbol-12-myristate-13-acetate in mixed human leukocyte cultures, Carcinogenesis 4:1313 (1983).
A. W. Hsie, L. Recio, D. S. Katz, C. Q. Lee, M. Wagner and R. L. Schenley, Evidence for reactive oxygen species inducing mutations in mammalian cells, Proc. Natl. Acad. Sci. USA 83:9616 (1986).
C. Borek and W. Troll, Modifiers of free radicals inhibit in vitro the oncogenic actions of X-rays, bleomycin and the tumor promoter 12-0-tetradecanoylphorbol-13-acetate, Proc. Natl. Acad. Sci. USA 80:1304 (1983).
T. W. Kensler, D. M. Bush and W. J. Kozumbo, Inhibition of tumor promotion by a biomimetic Superoxide dismutase, Science 221:75 (1983).
B. D. Goldstein, G. Witz, M. Amoruso, D. S. Stone, and W. Troll, Stimulation of human polymorphonuclear leukocyte Superoxide anion radical production by tumor promoters, Cancer Lett. 11:257 (1981).
J. M. Whitcomb and A. G. Schwartz, Dehydroepiandrosterone and 16α-Br-epiandrosterone inhibit 12-0-tetradecanoylphorbol-13-acetate stimulation of Superoxide radical production by human polymorphonuclear leukocytes, Carcinogenesis 6:333 (1985).
A. G. Schwartz and L. L. Pashko, Food restriction inhibits [3H] 7, 12-di-methylbenz(a)anthracene binding to mouse skin DNA and tetradecanoylphorbol-13-acetate stimulation of epidermal [3H]thymidine incorporation, Anticancer Res. 6:1279 (1986).
S. Dessi, B. Batetta, D. Pulixi, A. Carrucciu, M. Armeni, M. F. Mulas and P. Pani, Modifying influence of fasting on DNA synthesis, cholesterol metabolism and HMP shunt enzymes in liver hyperplasia induced by lead nitrate, Fourth Sardinian International Meeting: Models and Mechanisms in Chemical Carcinogenesis, abstract, (1987).
E. Aizu, T. Nakadate, S. Yamamoto and R. Kato, Inhibition of 12-0-tetradecanoylphorbol-13-acetate mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects, Carcinogenesis 7:1809 (1986).
P. A. Craven, J. Pfanstiel and F. R. DeRubertis, Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids, J. Clin. Invest. 79:532 (1987).
Y. S. Bakhle, Synthesis and catabolism of cyclo-oxygenase product, Brit. Med. Bull. 39:214 (1983).
G. W. Taylor and H. R. Morris, Lipoxygenase pathways, Brit. Med. Bull. 39:219 (1983).
S. M. Fischer and L. M. Adams, Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism, Cancer Res. 45:3130 (1985).
G. Fürstenberger and F. Marks, Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis, Biochem. Biophys. Res. Commun. 84:1103 (1978).
L. A. Hastings, L. L. Pashko, M. L. Lewbart and A. G. Schwartz, Dehydroepiandrosterone and two structural analogs inhibit tetradecanoylphorbol-13-acetate stimulation of prostaglandin E2 content in mouse skin, submitted.
M. Nagao, T. Ishibashi, T. Okayasu and Y. Imai, Possible involvement of NADPH-cytochrome P-450 reductase and cytochrome b5 on ß-ketostearoyl-CoA reduction in microsomal fatty acid chain elongation supported by NADPH, FEBS Letters 155:11 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schwartz, A.G., Pashko, L.L., Hastings, L.A., Whitcomb, J.H., Lewbart, M.L. (1988). Chemoprevention of Experimental Tumorigenesis by Dehydroepiandrosterone and Structural Analogs. In: Feo, F., Pani, P., Columbano, A., Garcea, R. (eds) Chemical Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9640-7_41
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9640-7_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9642-1
Online ISBN: 978-1-4757-9640-7
eBook Packages: Springer Book Archive